75 related articles for article (PubMed ID: 28630139)
1. Functional interfaces between TICAM-2/TRAM and TICAM-1/TRIF in TLR4 signaling.
Funami K; Matsumoto M; Oshiumi H; Inagaki F; Seya T
Biochem Soc Trans; 2017 Aug; 45(4):929-935. PubMed ID: 28630139
[TBL] [Abstract][Full Text] [Related]
2. Type I interferon signaling contributes to the bias that Toll-like receptor 4 exhibits for signaling mediated by the adaptor protein TRIF.
Kolb JP; Casella CR; SenGupta S; Chilton PM; Mitchell TC
Sci Signal; 2014 Nov; 7(351):ra108. PubMed ID: 25389373
[TBL] [Abstract][Full Text] [Related]
3. Structural insights into the role of deleterious mutations at the dimeric interface of Toll-like receptor interferon-β related adaptor protein.
Verma S; Menon R; Sowdhamini R
Proteins; 2024 May; ():. PubMed ID: 38814166
[TBL] [Abstract][Full Text] [Related]
4. The COP II adaptor protein TMED7 is required to initiate and mediate the delivery of TLR4 to the plasma membrane.
Liaunardy-Jopeace A; Bryant CE; Gay NJ
Sci Signal; 2014 Jul; 7(336):ra70. PubMed ID: 25074978
[TBL] [Abstract][Full Text] [Related]
5. Crystallization and X-ray diffraction analysis of the N-terminal domain of the Toll-like receptor signalling adaptor protein TRIF/TICAM-1.
Ullah MO; Ve T; Dkhar J; Alaidarous M; Ericsson DJ; Sweet MJ; Mansell A; Kobe B
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Jul; 69(Pt 7):766-70. PubMed ID: 23832204
[TBL] [Abstract][Full Text] [Related]
6. STING Requires the Adaptor TRIF to Trigger Innate Immune Responses to Microbial Infection.
Wang X; Majumdar T; Kessler P; Ozhegov E; Zhang Y; Chattopadhyay S; Barik S; Sen GC
Cell Host Microbe; 2016 Sep; 20(3):329-341. PubMed ID: 27631700
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for concerted recruitment and activation of IRF-3 by innate immune adaptor proteins.
Zhao B; Shu C; Gao X; Sankaran B; Du F; Shelton CL; Herr AB; Ji JY; Li P
Proc Natl Acad Sci U S A; 2016 Jun; 113(24):E3403-12. PubMed ID: 27302953
[TBL] [Abstract][Full Text] [Related]
8. TRIF-dependent signaling and its role in liver diseases.
Hu L; Cheng Z; Chu H; Wang W; Jin Y; Yang L
Front Cell Dev Biol; 2024; 12():1370042. PubMed ID: 38694821
[TBL] [Abstract][Full Text] [Related]
9. Structural Evolution of TIR-Domain Signalosomes.
Nimma S; Gu W; Maruta N; Li Y; Pan M; Saikot FK; Lim BYJ; McGuinness HY; Zaoti ZF; Li S; Desa S; Manik MK; Nanson JD; Kobe B
Front Immunol; 2021; 12():784484. PubMed ID: 34868065
[TBL] [Abstract][Full Text] [Related]
10. Macrophage deletion of Noc4l triggers endosomal TLR4/TRIF signal and leads to insulin resistance.
Qin Y; Jia L; Liu H; Ma W; Ren X; Li H; Liu Y; Li H; Ma S; Liu M; Li P; Yan J; Zhang J; Guo Y; You H; Guo Y; Rahman NA; Wołczyński S; Kretowski A; Li D; Li X; Ren F; Li X
Nat Commun; 2021 Oct; 12(1):6121. PubMed ID: 34675215
[TBL] [Abstract][Full Text] [Related]
11. RHBDL4-triggered downregulation of COPII adaptor protein TMED7 suppresses TLR4-mediated inflammatory signaling.
Knopf JD; Steigleder SS; Korn F; Kühnle N; Badenes M; Tauber M; Theobald SJ; Rybniker J; Adrain C; Lemberg MK
Nat Commun; 2024 Mar; 15(1):1528. PubMed ID: 38453906
[TBL] [Abstract][Full Text] [Related]
12. Distinct functional motifs within the IL-17 receptor regulate signal transduction and target gene expression.
Maitra A; Shen F; Hanel W; Mossman K; Tocker J; Swart D; Gaffen SL
Proc Natl Acad Sci U S A; 2007 May; 104(18):7506-11. PubMed ID: 17456598
[TBL] [Abstract][Full Text] [Related]
13. A peptide antagonist of the TLR4-MD2 interaction.
Slivka PF; Shridhar M; Lee GI; Sammond DW; Hutchinson MR; Martinko AJ; Buchanan MM; Sholar PW; Kearney JJ; Harrison JA; Watkins LR; Yin H
Chembiochem; 2009 Mar; 10(4):645-9. PubMed ID: 19184989
[TBL] [Abstract][Full Text] [Related]
14. Toll-like Receptors and the Control of Immunity.
Fitzgerald KA; Kagan JC
Cell; 2020 Mar; 180(6):1044-1066. PubMed ID: 32164908
[TBL] [Abstract][Full Text] [Related]
15. Signalling, sorting and scaffolding adaptors for Toll-like receptors.
Luo L; Lucas RM; Liu L; Stow JL
J Cell Sci; 2019 Dec; 133(5):. PubMed ID: 31889021
[TBL] [Abstract][Full Text] [Related]
16. SLAMF1 is required for TLR4-mediated TRAM-TRIF-dependent signaling in human macrophages.
Yurchenko M; Skjesol A; Ryan L; Richard GM; Kandasamy RK; Wang N; Terhorst C; Husebye H; Espevik T
J Cell Biol; 2018 Apr; 217(4):1411-1429. PubMed ID: 29440514
[TBL] [Abstract][Full Text] [Related]
17. Regulation of TRIF-mediated innate immune response by K27-linked polyubiquitination and deubiquitination.
Wu X; Lei C; Xia T; Zhong X; Yang Q; Shu HB
Nat Commun; 2019 Sep; 10(1):4115. PubMed ID: 31511519
[TBL] [Abstract][Full Text] [Related]
18. TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling.
Ciesielska A; Matyjek M; Kwiatkowska K
Cell Mol Life Sci; 2021 Feb; 78(4):1233-1261. PubMed ID: 33057840
[TBL] [Abstract][Full Text] [Related]
19. YULINK regulates vascular formation in zebrafish and HUVECs.
Lin HH; Kuo MW; Fan TC; Yu AL; Yu J
Biol Res; 2023 Feb; 56(1):7. PubMed ID: 36843032
[TBL] [Abstract][Full Text] [Related]
20. CB1 as a novel target for Ginkgo biloba's terpene trilactone for controlling chemotherapy-induced peripheral neuropathy (CIPN).
Samandar F; Tehranizadeh ZA; Saberi MR; Chamani J
J Mol Model; 2022 Aug; 28(9):283. PubMed ID: 36044079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
